Psychedelic therapy has gained traction as a promising approach to mental health treatment, but with this rise comes a myriad of ethical challenges stemming from the complexities of power dynamics and unclearly defined roles between “therapists” and “patients” in dual altered-state experiences. From ethical gray areas to severe violations such as sexual and financial abuse of patients, this panel aims to delve into these ethical dilemmas. Panelists will explore questions such as: What is ethical? Why does unethical behavior occur? How should the psychedelics community respond to bad actors?